P26.02 A Phase II Trial of Neoadjuvant Osimertinib for Surgically Resectable EGFR-Mutant Non-Small Cell Lung Cancer: Updated Results
Saved in:
Published in | Journal of thoracic oncology Vol. 16; no. 10; pp. S1039 - S1040 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Inc
01.10.2021
|
Online Access | Get full text |
Cover
Loading…
ISSN: | 1556-0864 1556-1380 |
---|---|
DOI: | 10.1016/j.jtho.2021.08.383 |